Supporting this mechanism, oral administration of the P2RX7 receptor inhibitor GSK1482160 suppresses MDE secretion, reduces hippocampal accumulation of misfolded tau, and improves cognitive deficits in a tauopathy AD mouse model [48]. The gene discussed is MAPT; the disease is Alzheimer disease.